Science
Mechanism of Action
This sophorolipid acts as a selective antimicrobial agent that physically destabilizes microbial biofilms—the protective shields used by acne-causing bacteria. By lowering surface tension and regulating lipid metabolism, it significantly reduces sebum overproduction and rebalances the cutaneous flora without the irritation associated with traditional surfactants.
Research
Clinical Evidence
High confidence4%
Key findings
- 01 Observed a 43% reduction in active acne lesions over a 28-day clinical trial.
- 02 Demonstrated Minimum Inhibitory Concentration (MIC) against C. acnes, effectively halting bacterial proliferation.
- 03 Successfully compromised the structural integrity and adhesion of established bacterial biofilms.
Transparency
Dusting Analysis
While this ingredient is effective at very low concentrations (0.03%) for microbial inhibition, clinical acne reduction is typically tied to concentrations near 4%. Formulae using less than 0.5% may provide microbiome support but likely won't deliver the significant lesion reduction seen in primary clinical trials.
The Formula
Formulation
Stability
Exceptional thermal and chemical stability; maintains integrity in high-salinity environments (up to 10% NaCl) and across a broad pH spectrum (3-12).
Synergies
- Salicylic Acid
- Niacinamide
- Probiotics
Conflicts
- Extremely acidic environments (below pH 3.0) may reduce foaming capacity
Safety
Safety Profile
Current CIR status is 'Insufficient Data' as of late 2023 pending further sensitization benchmarks, though the source Madhuca oil has a long history of safe use in food and traditional medicine.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A sophisticated, bio-based alternative to traditional anti-acne agents that offers targeted microbial control without compromising the skin barrier.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources